Timber Pharmaceuticals Total Revenue

Timber Pharmaceuticals (TMBR) currently reports a total revenue of $83K as of June 2023. That compares with $42K in the prior-year period — up 98.8% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Timber Pharmaceuticals's total revenue history and peer comparisons.

Timber Pharmaceuticals's total revenue increased from $42K to $83K — a 98.8% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Timber Pharmaceuticals's total revenue of $83K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Timber Pharmaceuticals reported $83K in total revenue as of June 2023. That compares with $42K in the prior-year period — up 98.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $83K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Timber Pharmaceuticals, and consider following TMBR for alerts when major investors trade the stock.